Publications
2012
Esmat, Gamal, Mohamed Hashem, Mona El-Raziky, Wafaa El-Akel, Suzan El-Naghy, Nehal El-Koofy, Rokaya El-Sayed, Rasha Ahmed, Mohamed Atta-Allah, Mohamed Abdel Hamid et al. "
Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children."
LIVER INTERNATIONAL 32 (2012): 449-456.
Abstractn/a
Wiersma, S. T., B. McMahon, J. M. Pawlotsky, C. L. Thio, M. Thursz, S. G. Lim, P. Ocama, G. Esmat, M. Mendy, D. Bell et al. "
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus (vol 31, pg 755, 2011)."
LIVER INTERNATIONAL 32 (2012): 174.
Abstractn/a
Yosry, Ayman, Mohamed Said, Gamal Esmat, Magdy Al-Serafy, Ashraf Omar, Wahid Doss, Dalia Omran, Yasmin Saad, Sanna Kamel, Akram Abdel-Bary et al. "
HLA Tissue Typing Has No Effect on the Outcome of Patients Undergoing a Living-donor Liver Transplant: A Single-center Experience in Egypt."
EXPERIMENTAL AND CLINICAL TRANSPLANTATION 10 (2012): 136-140.
Abstractn/a
ElHefnawi, Mahmoud, Mahmoud Abdalla, Safaa Ahmed, Wafaa elakel, Gamal Esmat, Maissa El Raziky, Shaima Khamis, and Marwa Hassan. "
Accurate prediction of response to Interferon-based therapy in Egyptian patients with Chronic Hepatitis C using machine-learning approaches." In
2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), 771-778., 2012.
Abstractn/a
Maher, Mohsen M., Sayed M. Shalaby, Gamal Esmat, Mohamed Abd El Adl Al-Sawey, Manal Zaghloul Maharan, Tarek M. Yosef, Wesam A. Ibrahim, Naglaa Zayed, Nesrine A. Mohamed, and Sarah Abdel Kader El-Nakeep. "
Light Chain Antigenic Determinants (kappa and gamma) Influence on the Treatment Outcome of Chronic Hepatitis C Infection in Egypt."
LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION 9 (2012): 2329-2333.
Abstractn/a
2011
Hatzakis, A., S. Wait, J. Bruix, M. Buti, M. Carballo, M. Cavaleri, M. Colombo, E. Delarocque-Astagneau, G. Dusheiko, G. Esmat et al. "
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference."
JOURNAL OF VIRAL HEPATITIS 18 (2011): 1-16.
Abstractn/a
Hezode, Christophe, Gideon M. Hirschfield, Wayne Ghesquiere, William Sievert, Maribel Rodriguez-Torres, Stephen D. Shafran, Paul J. Thuluvath, Harvey A. Tatum, Imam Waked, Gamal E. Esmat et al. "
BMS-790052, A NS5A REPLICATION COMPLEX INHIBITOR, COMBINED WITH PEGINTERFERON ALFA-2A AND RIBIVIRIN IN TREATMENT-NAIVE HCV-GENO-TYPE 1 OR 4 PATIENTS: PHASE 2B AI444010 STUDY INTERIM WEEK 12 RESULTS."
HEPATOLOGY 54 (2011): 474A-475A.
Abstractn/a
El Awady, Mostafa K., Mohamed A. Anany, Gamal Esmat, Naglaa Zayed, Ashraf A. Tabll, Amr Helmy, Abdel Rahman El Zayady, Mohga S. Abdalla, Hayat M. Sharada, Maissa El Raziky et al. "
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy."
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26 (2011): 843-850.
Abstractn/a
Hashem, Mohamed, Hanaa El-Karaksy, Mohamed T. Shata, Maha Sobhy, Heba Helmy, Suzan El-Naghi, Gehan Galal, Zainab Z. Ali, Gamal Esmat, Sayed F. Abdelwahab et al. "
Strong Hepatitis C Virus (HCV)-specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children."
JOURNAL OF INFECTIOUS DISEASES 203 (2011): 854-861.
Abstractn/a
El Tayebi, H. M., W. Salah, I. H. El Sayed, E. M. Salam, A. R. N. Zekri, N. Zayed, E. S. Salem, G. Esmat, and A. I. Abdelaziz. "
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients."
BIOMARKERS 16 (2011): 346-354.
Abstractn/a